Sanela Tarabar

811 total citations
14 papers, 452 citations indexed

About

Sanela Tarabar is a scholar working on Pharmacology, Oncology and Dermatology. According to data from OpenAlex, Sanela Tarabar has authored 14 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Oncology and 3 papers in Dermatology. Recurrent topics in Sanela Tarabar's work include Dermatology and Skin Diseases (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Pharmacology and Obesity Treatment (2 papers). Sanela Tarabar is often cited by papers focused on Dermatology and Skin Diseases (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Pharmacology and Obesity Treatment (2 papers). Sanela Tarabar collaborates with scholars based in United States, United Kingdom and Germany. Sanela Tarabar's co-authors include Elena Peeva, Vivek Pradhan, Michael S. Vincent, Deron Galusha, Kanta Sircar, Martin D. Slade, William P. Esler, Arthur Bergman, Peter Rabinowitz and Christopher Banfield and has published in prestigious journals such as Brain, Journal of Hepatology and Journal of the American Academy of Dermatology.

In The Last Decade

Sanela Tarabar

14 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sanela Tarabar United States 11 118 89 88 77 76 14 452
Morteza Bagheri Iran 13 47 0.4× 65 0.7× 70 0.8× 112 1.5× 133 1.8× 64 629
Chenchen Xu China 13 158 1.3× 50 0.6× 50 0.6× 38 0.5× 133 1.8× 40 504
Victoria Lyo United States 10 103 0.9× 63 0.7× 105 1.2× 42 0.5× 122 1.6× 33 635
Yuichi Yageta Japan 14 107 0.9× 70 0.8× 146 1.7× 164 2.1× 255 3.4× 14 665
Yu‐Huei Huang Taiwan 17 124 1.1× 329 3.7× 91 1.0× 359 4.7× 91 1.2× 66 846
Matteo Barcella Italy 15 113 1.0× 19 0.2× 140 1.6× 100 1.3× 307 4.0× 31 721
Aroa S. Maroto Spain 16 51 0.4× 66 0.7× 75 0.9× 76 1.0× 258 3.4× 29 609
E Brunetti Italy 14 28 0.2× 52 0.6× 41 0.5× 65 0.8× 80 1.1× 19 399
Tomasz Śliwa Poland 7 42 0.4× 11 0.1× 49 0.6× 134 1.7× 77 1.0× 11 386

Countries citing papers authored by Sanela Tarabar

Since Specialization
Citations

This map shows the geographic impact of Sanela Tarabar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanela Tarabar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanela Tarabar more than expected).

Fields of papers citing papers by Sanela Tarabar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanela Tarabar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanela Tarabar. The network helps show where Sanela Tarabar may publish in the future.

Co-authorship network of co-authors of Sanela Tarabar

This figure shows the co-authorship network connecting the top 25 collaborators of Sanela Tarabar. A scholar is included among the top collaborators of Sanela Tarabar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanela Tarabar. Sanela Tarabar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Landis, Megan N., Stacy Smith, Gabriel Berstein, et al.. (2023). Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group study. British Journal of Dermatology. 189(1). 33–41. 18 indexed citations
2.
Eichenfield, Lawrence F., Sanela Tarabar, Seth Forman, et al.. (2023). Efficacy and Safety of PF-07038124 in Patients With Atopic Dermatitis and Plaque Psoriasis. JAMA Dermatology. 160(2). 156–156. 11 indexed citations
3.
Singh, Ravi Shankar Prasad, Vivek Pradhan, Sanela Tarabar, et al.. (2022). Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis in a phase 2b, randomized, double-blind, placebo-controlled study. Journal of the American Academy of Dermatology. 87(2). 333–342. 40 indexed citations
4.
Landis, Megan N., Stacy Smith, Zoé Kececioglu Draelos, et al.. (2022). Efficacy and safety of topical brepocitinib for the treatment of mild-to-moderate atopic dermatitis: a phase IIb, randomized, double-blind, vehicle-controlled, dose-ranging and parallel-group study. British Journal of Dermatology. 187(6). 878–887. 43 indexed citations
5.
Tarabar, Sanela, Debra Kelsh, Bradley Vince, et al.. (2020). Phase I Pharmacokinetic Study of Fixed-Dose Combinations of Ibuprofen and Acetaminophen in Healthy Adult and Adolescent Populations. Drugs in R&D. 20(1). 23–37. 10 indexed citations
6.
Bergman, Arthur, Santos Carvajal‐Gonzalez, Sanela Tarabar, et al.. (2020). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Liver‐Targeting Acetyl‐CoA Carboxylase Inhibitor (PF‐05221304): A Three‐Part Randomized Phase 1 Study. Clinical Pharmacology in Drug Development. 9(4). 514–526. 50 indexed citations
7.
Neelakantan, Srividya, Barry S. Oemar, Natalie Rath, et al.. (2020). Safety, Tolerability, and Pharmacokinetics of PF‐06823859, an Anti–Interferon β Monoclonal Antibody: A Randomized, Phase I, Single‐ and Multiple‐Ascending‐Dose Study. Clinical Pharmacology in Drug Development. 10(3). 307–316. 10 indexed citations
8.
Thompson, Allison, Joseph M. Severs, Ingrid L. Scully, et al.. (2019). Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults. Vaccine. 37(42). 6201–6207. 77 indexed citations
9.
10.
Peeva, Elena, Martin R. Hodge, Elizabeth Kieras, et al.. (2018). Evaluation of a Janus kinase 1 inhibitor, PF‐04965842, in healthy subjects: A phase 1, randomized, placebo‐controlled, dose‐escalation study. British Journal of Clinical Pharmacology. 84(8). 1776–1788. 38 indexed citations
11.
McDonnell, Aoibhinn, Betsy R. Schulman, Zahid Ali, et al.. (2016). Inherited erythromelalgia due to mutations inSCN9A:natural history, clinical phenotype and somatosensory profile. Brain. 139(4). 1052–1065. 59 indexed citations
12.
13.
Naganawa, Mika, Rikki N. Waterhouse, Nabeel Nabulsi, et al.. (2016). First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430. Journal of Nuclear Medicine. 57(9). 1388–1395. 24 indexed citations
14.
Rabinowitz, Peter, Kanta Sircar, Sanela Tarabar, Deron Galusha, & Martin D. Slade. (2005). Hearing Loss in Migrant Agricultural Workers. Journal of Agromedicine. 10(4). 9–17. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Morteza Bagheri Breakdown of academic impact, for papers by Chenchen Xu Breakdown of academic impact, for papers by Victoria Lyo Breakdown of academic impact, for papers by Yuichi Yageta Breakdown of academic impact, for papers by Yu‐Huei Huang Breakdown of academic impact, for papers by Matteo Barcella Breakdown of academic impact, for papers by Aroa S. Maroto Breakdown of academic impact, for papers by E Brunetti Breakdown of academic impact, for papers by Tomasz Śliwa
Rankless by CCL
2026